Edra
European Annals of Allergy and Clinical Immunology THE OFFICIAL JOURNAL OF AAITO THE OFFICIAL JOURNAL OF SPAIC HOME PAGE
2022 Impact Factor
2.3
EDITORS IN CHIEF
M. B. Bilò (Italy)
P. Carreiro-Martins (Portugal)

DEPUTY EDITORS
R. Rodrigues Alves (Portugal)
D. Villalta (Italy)
 
ASSOCIATE EDITORS
R. Asero (Italy)
M. Branco Ferreira (Portugal)
L. Cecchi (Italy)
E. Scala (Italy)
D. Solé (Brasil)
G. Sturm (Austria)

EDITORIAL BOARD
I. Agache (Romania)
I. Annesi Maesano (France)
L. Antonicelli (Italy)
G. Azizi (Iran)
L.M. Borrego (Portugal)
K. Brockow (Germany)
S. Bavbek (Turkey)
E. Cichocka-Jarosz (Poland)
M. Cugno (Italy)
L. Delgado (Portugal)
P. Demoly (France)
G. D'Amato (Italy)
S. Durham (UK)
M. Faber (Belgium)
M. Fernandez-Rivas (Spain)
J. Fonseca (Portugal)
ZS. Gao (China)
G.P. Girolomoni (Italy)
E. Goudouris (Brasil)
A. Grumach (Brasil)
G. Kostantinou (Greece)
F. Levi-Shaffer (Israel)
M. Maurer (Germany)
L. Mayorga (Spain)
C. Micheletto (Italy)
M. Morais de Almeida (Portugal)
G. Moscato (Italy)
A. Musarra (Italy)
C. Nunes (Portugal)
M. Ollert (Lussemburgo)
P. Parronchi (Italy)
G. Passalacqua (Italy)
E. Pedro (Portugal)
A. Perino (Italy)
O. Quercia (Italy)
A. Romano (Italy)
G. Scadding (UK)
A. Todo Bom (Portugal)
A. Tedeschi (Italy)
R. van Ree (Netherland)
S. Voltolini (Italy)

FOUNDERS
F. Bonifazi (Italy)
A. Sabbah (France)
************************* 

Chief Executive Officer 
Ludovico Baldessin

Editorial Coordinator
Barbara Moret

Publishing Editor
Jessica Guenzi
j.guenzi@lswr.it

Sales
dircom@lswr.it

EDRA SpA 
Via G. Spadolini, 7
20141 Milano - Italy
Ph. 0039 (0)2-88184.1
Fax 0039 (0)2-88184.301
www.edraspa.it


Follow us on LinkedIn



European Annals of Allergy and Clinical Immunology ISSN 1764-1489

2024

Guide for Authors



LAST UPDATE: FEBRUARY 2023

Journal scope and general principles

European Annals of Allergy and Clinical Immunology is a bimonthly peer-reviewed publication.

As official Journal of the "Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri" (Association of Italian Hospital Allergists and Immunologists - AAIITO (www.aaiito.it)) and the "Sociedade Portuguesa de Alergologia e Imunologia Clinica" (Portuguese Society of Allergology and Clinical Immunology - SPAIC (www.spaic.pt)), it collects reviews, original works concerning etiology, diagnosis and treatment of allergic and immunological disorders. It includes a section of information coming from the main international health associations and authorities. European Annals of Allergy and Clinical Immunology represents to the specialist a means for updating and widening in research and clinical practice field.

European Annals of Allergy and Clinical Immunology will accept for publication suitable manuscripts dealing with the aetiology, diagnosis and treatment of allergic and immunologic diseases. These might include the study of methods of controlling immunologic and allergic reactions, human and animal models of hypersensitivity and other aspects of basic and applied clinical allergy in its broadest sense. Paper reporting the results of drug trials will be considered.

European Annals of Allergy and Clinical Immunology also publishes solicited and usolicited review articles on subjects of topical interest to clinical and experimental allergy.

Manuscripts are considered for publication with the understanding that they do not contain previously published material, have not been published previously and are not currently under review at another journal. All manuscripts must also be accompanied by an adequately compiled and signed Journal Publishing Agreement.

If the manuscript is accepted for publication in European Annals of Allergy and Clinical Immunology, the authors guarantee that it will not be published elsewhere in any other language without permission from the copyright holder.

The authors of manuscripts that include illustrations, tables and/or sections of text that have been published previously elsewhere must request permission to reproduce the material from the copyright holder. This permission must be presented in written form during submission of the manuscript. In the absence of such permission, all material received will be regarded as the authors' own work.

Manuscripts that report the results of research conducted on human subjects must include a declaration in the Materials and Methods section that the study protocol was approved by the competent Ethics Committee, that the study was conducted in accordance with the ethical standards established in the Declaration of Helsinki of 1946 (World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053), and that informed consent was obtained from all participants before enrolment in the study. All details that could reveal the identity of a patient (including initials of the patient name and unnecessary reference to personal data such as occupation and residence) must be omitted from the text and illustrative materials.

If experiments have been conducted on animals, the study must have been conducted in accordance with the International Animal Research Regulations (Institute of Medicine (US); National Research Council (US). International Animal Research Regulations: Impact on Neuroscience Research: Workshop Summary. Washington (DC): National Academies Press (US); 2012. doi: 10.17226/13322) and such adherence must be explicitly stated in the manuscript.

The decision to publish a manuscript is based on a double blind peer-review process, and acceptance of an article will be based on criteria of originality, relevance, and scientific content of the contribution. The authors may be requested to modify the text based on the comments of reviewers. Statements made in the manuscripts are the responsibility of the author and not of the editor. The opinions expressed in the articles are those of the authors and may not reflect the position of the editors.

Each author must complete and sign a Conflicts of interest disclosure form, which specifies all economic, personal and professional relationships that could become a conflict of interests, that could be perceived as a possible conflict of interests, or that could influence the work of the author described in the manuscript. The form must be sent with the manuscript. The editorial office reserves the right to reject any manuscript that does not conform to the above-described instructions. The authors will be held responsible for any false declarations or noncompliance with the instructions specified above.


SUBMISSION PROCEDURE

We request that all manuscripts should be submitted online at:  https://www2.cloud.editorialmanager.com/eaaci/default2.aspx

Authors are also requested to return both completed and signed Journal Publishing Agreement and Conflict of interest disclosure forms by e-mail to Journal Publishing Editor j.guenzi@lswr.it

Cover letter

For the purpose of publication, the Authors must sign a cover letter in which the following information is reported in a declaration signed by the corresponding Author:

  • the manuscript has neither been previously published, nor under consideration for publication elsewhere; the Authors have obtained written permission for the reproduction of images, figures or algorithms protected by copyright; if the article is published, the Author's rights concerning the article itself will be transferred to the Editor;
  • existence or not of economic or other types of conflicts of interest regarding the article presented (attach also the completed and signed Conflicts of interest disclosure form mentioned above);
  • the manuscript was read and approved by all Authors;
  • for original articles, formal approval by the local Ethics Committee of the research proposed for publication is available.

Title page preparation (Word Format) 

Title page must contain:

- manuscript title;

- names of the Authors: full names of the authors and complete surnames of each Author; each Author's affiliation must be IN ENGLISH;

- name and address of the Institution where the work was carried out;

- list of the ORCIDs of the authors who own one.

- Information about Corresponding author: 

- complete Name and Surname

- complete address;

- ORCID Identification; 

- e-mail address to which the PDF of the drafts will be sent.

Manuscript preparation (Word Format) 

REMEMBER TO DEVELOP THE MANUSCRIPT WITH THE WORD LINE NUMBERS.   

Follow the rules according to manuscript type:

Original article 

  • Abstract (250 word maximum) for original articles must be subdivided in the following paragraphs: Background. Xxxxxxxx. Methods. Xxxxxxxx. Results. Xxxxxxxx. Conclusions. Xxxxxxxx. 
    In case of clinical trials, at the end of the abstract, indicate (if applicable) ID code and the repository of the study registration. 
  • Impact statement is required. 
  • Main text should be subdivided in the following sections:
    -Introduction
    -Materials and methods
    -Results
    -Discussion (conclusion here included).
  • Max. 6 tables or 6 figures or a mix.

Review article

  • Abstract (250 word maximum) for reviews should be unstructured or subdivided in the following paragraphs: Background. Xxxxxxxx. Methods. Xxxxxxxx. Results. Xxxxxxxx. Conclusions. Xxxxxxxx.
    At the end of the abstract indicate (if applicable) ID code and the repository of the study registration. 
  • Impact statement is required 
  • Main text can be organized according to the authors' preference or it could be divided in the following sections: 
    -Introduction
    -Methods
    -Results
    -Discussion (conclusion here included).
  • Max. 6 tables or 6 figures or a mix. 

Position paper

  • Abstract (250 word maximum) for position paper should be unstructured.
  • Impact statement is required.
  • Main text can be organized according to the authors' preference.
  • Max. 6 tables or 6 figures or a mix. 

Letter to the Editor 

  • Abstract is not required. 
  • Impact statement is not required. 
  • Division into paragraphs is not required 
  • It should begin with: "To the Editor," 
  • Main text should be 600 words and 10 references maximum. 
  • Max. 2 tables or 2 figures or a mix. 

Commentary/Correspondence 
(on articles published in the Journal)

  • Abstract is not required. 
  • Impact statement is not required 
  • Main text should be 600 words and 10 references maximum. 
  • Max. 2 tables or 2 figures or a mix.

All the manuscripts:

-Key words: indicate 3-5 key words under the abstract. 

The style of writing should conform to English usage and syntax. Authors whose mother tongue is not English are urged to have their manuscripts checked for linguistic correctness before submission. Slang, technical jargon, obscure abbreviations and abbreviated phrasing should be avoided.  

-At the end of the manuscript, before the References listed, indicate the Compliance with Ethical Standards statements:

  • Fundings
  • Contributions of each author. The authors should be identified with initials, e.g.: Maria Beatrice Bilò is MBB; Danilo Villalta is DV and with at least one of the following roles, according to the CRediT (Contributor Roles Taxonomy):Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing. For more information, refer to: https://credit.niso.org/.
  • Conflict of interests
  • Acknowledgments are not mandatory

-References

Editorial Office suggests to use references no older than 6 years (Reviews excluded). The aim is an up-to-date bibliography. 

References should be in the order:
-the order number corresponding with that of appearance in the text;
-the author's surname(s), followed by initial of first name; when there are more than 6 authors, the exceeding authors must be replaced by the word et al.
-the title of the work, in the original language.

-For journals: usual title abbreviations according to international nomenclature and in the order: year, volume number, issue number (in parenthesis), first and last page numbers of the work. Doi. 

For example: Bodtger U, Linnegerg A. Remission of allergic rhinitis: An 8-year observational study. J Allergy Clin Immunol. 2004;114(6):1384-8. doi: 10.1016/j.jaci.2004.08.039.

-For books: name of the author/editor, title, publisher/institution, town where published, first and last page number of the work.
For example: Paupe J, Scheinman P (eds). Allergologie Pédiatrique. Flammarion, Paris, 1988: pp. 324-42. 


When cited in the text, references should be written as follows: (1, 2) not superscript. Do not write the references using uppercase, small caps or italics. For abbreviation of titles, use the international standards from Index Medicus.

-Tables

All tables must be submitted separately from the primary manuscript. Add them in files in Word format. Tables must be identified and referred in the manuscript with roman numerals and accompanied by a brief caption (e.g. table IV).

Tables will not be accepted in PowerPoint, PDF or JPG formats, which require retyping of the text for uniformity of style with journal graphics.


-Figures

The figures (i.e., photographs, graphs, and diagrams, including flow charts) themselves should be submitted separately from the manuscript file (one file for each figure). Each figure should be numbered with an arabic numeral (according to its citation in the text). For composite figures, each component should be labeled with lowercase letters (e.g., figure 1A).

Use HELVETICA font for graphics' elements. Photographs, graphs, diagrams, and flow charts must be supplied in one of the following formats: JPG (high resolution: min 300 dpi), TIFF (high resolution: min 600 dpi).

NOTE: Figures must be presented separately, not inserted in the manuscript text and must not contain trade names or bibliographic references.

Legends: Captions for figures are to be provided in the text file at the end of the manuscript. DO NOT incorporate captions to figures.

Illustrative material included in the article should ideally be unprotected by copyright. For tables or figures that have already been published (by the authors or others), permission to reproduce must be obtained from the copyright holder (in generally, the journal in which the material was originally published) and attached to the submission. Failure to obtain this permission prior to submission can delay publication of an accepted manuscript.

Authors should make sure that photographs of patients contain no identifying features. The patient must be asked to provide written informed consent to the publication of the photograph.

In addition, the Publisher reserves the right to not publish images not conforming to these requirements, which could affect the graphical quality of the journal.

-Acronyms, abbreviations, units of measurements

European Annals of Allergy and Clinical Immunology recognizes the adoption of the International Systems of Units (SI-Units). Acronyms, abbreviations, and units of measurements without a legend and/or incomprehensible are not permitted. When necessary, a list of abbreviations may be inserted after the abstract.

---------------------------------------------------------------------------------------

Acceptance of submissions

Submitted contributions are accepted for publication on the basis of scientific interest and relevance for European Annals of Allergy and Clinical Immunology, at the final discretion of the Editor in Chief, who will have blinded written evaluations from at least two anonymous reviewers.

The Journal is published in open access, without any article processing charge for the authors in case of acceptance.

Proofreading

Proofreading is the responsibility of the Authors regarding content and of the Editors regarding the technical part. The proofs for correction will be sent to the corresponding Author indicated in the manuscript. These must be corrected and returned to the editorial office by the date indicted in the accompanying letter and within 3 working days of their receipt.

After this deadline, ex officio correction and/or postponing of publication will occur, depending on the editorial priority of the Editor in Chief.

Responses received after the indicated date and requests for sending to another or more than one Author, different from the one indicated in the manuscript, will not be accepted.

NOTE: Proofreading corrections must avoid modifying the graphics already defined or modifying the content so to require a new peer-review process.

----------------------------------------------------------------------------------------

HOW TO WRITE AN INDEXABLE PAPER (SEO PRINCIPLES)

- Do not use too long sentences. Alternating short and medium lenght sentences could be useful.

- Use 2 key words in the first 65 characters of the title and in the first 2 lines of the abstract.

- Other key words should be spread throghout the abstract (up to 6 times) and the manuscript in a well-contexualized way.

- Key words are single words and short sentences.

- Tool to consult to search key words: GoogleTrends.


AUTHOR GUIDELINES